SCHEMBL4910029

SCHEMBL4910029

COC(=O)c1cc(C(=O)N2CC[C@H](C)Nc3ccccc32)ccc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.39
MAPT P10636 3/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
BRD4 O60885 2/20 0.36
AVPR2 P30518 1/20 0.36
AVPR1A P37288 1/20 0.36
ALDH1A1 P00352 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
MAPK1 P28482 1/20 0.36
SPTLC2 O15270 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906946 0.89 GPBAR1 (0.41) GPBAR1MAPTBRD4AVPR2AVPR1A
SCHEMBL4902269 0.86 PTPN2 (0.35) GPBAR1MAPTBRD4ALDH1A1KDM4E
SCHEMBL4904274 0.86 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DBRD4
SCHEMBL4915030 0.86 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DBRD4
SCHEMBL4902302 0.84 TSHR (0.41) GPBAR1MAPTBRD4AVPR1AALDH1A1
SCHEMBL4907240 0.84 GPBAR1 (0.42) GPBAR1MAPTPDE4APDE4BPDE4C
SCHEMBL4912334 0.84 GPBAR1 (0.42) GPBAR1MAPTPDE4APDE4BPDE4C
SCHEMBL4911878 0.84 GPBAR1 (0.34) GPBAR1MAPTBRD4AVPR2ALDH1A1
SCHEMBL4910046 0.84 BRD4 (0.36) GPBAR1MAPTBRD4AVPR2AVPR1A
SCHEMBL4911740 0.84 BRD4 (0.37) GPBAR1MAPTPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076760-A1 2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION WAKAMOTO PHARMACEUTICAL CO., LTD (JP) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076760-A1 2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION GABRA5, GABRA1, GABRB1 GPBAR1 52/4885MAPT 3584/4885PDE4A 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.